{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T01:18:32Z","timestamp":1762219112685,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.neurol.2025.04.007","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T07:22:21Z","timestamp":1745911341000},"page":"571-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The safety of COVID-19 vaccines in a large French series of patients with neuromuscular conditions and the impacts of vaccination on their daily lives"],"prefix":"10.1016","volume":"181","author":[{"given":"M.","family":"Barnay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Foubert-Samier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-H.","family":"Violleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Campana-Salort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Cintas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lafor\u00eat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"P\u00e9r\u00e9on","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Tard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Sirma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Attarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2025.04.007_bib0125","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2025.04.007_bib0130","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape","volume":"21","author":"Tregoning","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.neurol.2025.04.007_bib0135","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s13023-021-02090-y","article-title":"A multicenter cross-sectional French study of the impact of COVID-19 on neuromuscular diseases","volume":"16","author":"Pisella","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.neurol.2025.04.007_bib0140","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1056\/NEJMoa2105290","article-title":"Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 vaccine","volume":"385","author":"Falsey","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2025.04.007_bib0145","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2025.04.007_bib0150","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.3201\/eid2712.211634","article-title":"Guillain-Barr\u00e9 syndrome associated with COVID-19 vaccination","volume":"27","author":"Shao","year":"2021","journal-title":"Emerg Infect Dis"},{"year":"2021","series-title":"La vaccination contre le COVID-19 pour les patients neuromusculaires en pratique","key":"10.1016\/j.neurol.2025.04.007_bib0155"},{"key":"10.1016\/j.neurol.2025.04.007_bib0160","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2025.04.007_bib0165","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1002\/mus.27255","article-title":"Parsonage Turner syndrome after COVID-19 vaccination","volume":"64","author":"Mahajan","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2025.04.007_bib0170","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/mus.27657","article-title":"Retrospective study on the safety of COVID-19 vaccination in myasthenia gravis","volume":"66","author":"Urra Pincheira","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2025.04.007_bib0175","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1212\/WNL.0000000000009566","article-title":"COVID-19 and neuromuscular disorders","volume":"94","author":"Guidon","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.04.007_bib0180","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/mus.27681","article-title":"COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies","volume":"66","author":"Gil-Vila","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2025.04.007_bib0185","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1212\/WNL.0000000000201376","article-title":"SARS-CoV-2 vaccination safety in Guillain-Barr\u00e9 syndrome, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy","volume":"100","author":"Baars","year":"2023","journal-title":"Neurology"},{"year":"2017","series-title":"Common terminology criteria for adverse events (CTCAE) Version 5. 0 (November 27, 2017)","key":"10.1016\/j.neurol.2025.04.007_bib0190"},{"key":"10.1016\/j.neurol.2025.04.007_bib0195","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/mus.24214","article-title":"The modified rankin scale to assess disability in myasthenia gravis: comparing with other tools","volume":"50","author":"Farrugia","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2025.04.007_bib0200","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/annrheumdis-2021-220272","article-title":"Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort","volume":"80","author":"Geisen","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.neurol.2025.04.007_bib0205","doi-asserted-by":"crossref","first-page":"e2109","DOI":"10.1212\/WNL.0000000000011669","article-title":"Impact of Coronavirus Disease 2019 in a French cohort of myasthenia gravis","volume":"96","author":"Sol\u00e9","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.04.007_bib0210","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/ene.15613","article-title":"Factors associated with the severity of COVID-19 outcomes in people with neuromuscular diseases: data from the International Neuromuscular COVID-19 Registry","volume":"30","author":"Pizzamiglio","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2025.04.007_bib0215","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3988\/jcn.2017.13.4.325","article-title":"The impacts of influenza infection and vaccination on exacerbation of myasthenia gravis","volume":"13","author":"Seok","year":"2017","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.neurol.2025.04.007_bib0220","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1016\/j.vaccine.2014.09.003","article-title":"Vaccination recommendations for patients with neuromuscular disease","volume":"32","author":"Esposito","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.neurol.2025.04.007_bib0225","doi-asserted-by":"crossref","first-page":"e0130922","DOI":"10.1128\/spectrum.01309-22","article-title":"Impact of sex and age on mRNA COVID-19 vaccine-related side effects in Japan","volume":"10","author":"Mori","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.neurol.2025.04.007_bib0230","doi-asserted-by":"crossref","first-page":"e0128361","DOI":"10.1371\/journal.pone.0128361","article-title":"Incidence of neuralgic amyotrophy (Parsonage Turner syndrome) in a primary care setting--a prospective cohort study","volume":"10","author":"van Alfen","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neurol.2025.04.007_bib0235","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/brain\/awac067","article-title":"COVID-19 vaccination and Guillain-Barr\u00e9 syndrome: analyses using the National Immunoglobulin Database","volume":"146","author":"Keh","year":"2023","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.neurol.2025.04.007_bib0240","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1038\/s41591-021-01556-7","article-title":"Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection","volume":"27","author":"Patone","year":"2021","journal-title":"Nat Med"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725005156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725005156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T01:14:38Z","timestamp":1762218878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378725005156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0035378725005156"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2025.04.007","relation":{},"ISSN":["0035-3787"],"issn-type":[{"type":"print","value":"0035-3787"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The safety of COVID-19 vaccines in a large French series of patients with neuromuscular conditions and the impacts of vaccination on their daily lives","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2025.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}